article · Zagazig University Medical Journal
Background: The degree of coronary artery disease (CAD) can be predicted using a variety of risk score techniques. However, their use in primary care settings is limited because most of them are complicated and call for sophisticated tools. A new risk score called CHA2DS2-VASc-HSF based on the CHA2DS2-VASc score was developed. Aim of the current study is to compare the efficacy of CHA2DS2-VASc-HSF score versus CHADS2 and CHA2DS2-VASc scores for the prediction of severity of coronary artery disease (CAD) to improve the management of CAD patients. Methods: This study was carried out in a cross-sectional fashion including 162 patients undergoing elective coronary angiography. Assessment of CHA2DS2-VASc-HSF, CHADS2 and CHA2DS2-VASc scores. Severity of CAD was assessed for all patients using Syntax score. Results: Syntax score was significantly higher among CHADS2 >1 group, CHA2DS2-VASc >2 group and CHA2DS2-VASc-HSF >4 group (P<0.001). There was a significant positive correlation between Syntax score with both CHA2DS2-VASc (r=0.572, P<0.001) and CHA2DS2-VASc-HSF (r=0.420, P<0.001). Also, on conducting ROC analysis on CHADS2-VASc-HSF score, analysis showed that CHADS2-VASc-HSF score had highest sensitivity (88.39%) and specificity (85.71%) at 4 with area under the curve was (0.907). After applying logistic regression analysis for predictors of high Syntax score (>22); CHA2DS2-VASc-HSF can be used as independent factor for predicting high Syntax score with more significant p value than CHA2DS2-VASc score (P=0.006 vs P=0.02). Conclusion: Our study concluded that CHA2DS2-VASc-HSF score is superior to CHADS2, CHA2DS2-VASc for prediction of CAD severity.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21608/zumj.2024.327576.3632
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.